Victor Sandor, Chief Medical Officer at ARRAY BIOPHARMA INC (ARRY), sold 312,032 shares at $17.70 ($5.5M) on 2018-03-09, disclosed to the SEC on 2018-03-09.
Open-market sale of $5.5M ARRY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.70 | 44,498 | $788K | 14.2% |
| 2 | $17.70 | 44,498 | $788K | 14.2% |
| 3 | $17.72 | 111,518 | $2.0M | 35.8% |
| 4 | $17.72 | 111,518 | $2.0M | 35.8% |
| Total | $17.71 avg | 312,032 | $5.5M | 100% |
| Filing → |
| ARRY | SELL | 2019-06-03 | $2.4M | — | Filing → |
| ARRY | SELL | 2019-05-28 | $3.1M | — | Filing → |
| ARRY | SELL | 2019-05-23 | $334K | — | Filing → |